News & Events

< Back to News Overview

A New Zealand drug that pioneers a wholly new approach totreating Parkinson's disease has been approved for a Phase II clinical trial tobegin in May.

01 / 05 / 2006

Please see the attached document(s) below.

Downloads

Download "A New Zealand drug that pioneers a wholly new approach totreating Parkinson's disease has been approved for a Phase II clinical trial tobegin in May." [45B]